Pfizer, DoHDA talks stall as PBS listing times blow out to almost two years

4 minute read


Cancer patients are being ‘abandoned’, advocates say, as access to a recommended treatment waits on pricing negotiations.


Cancer patients are being ‘abandoned’, advocates say, as access to a recommended treatment waits on pricing negotiations.

This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.

End of content

No more pages to load

Log In Register ×